ResearcherGuangzhou First People's HospitalActive in the last 2 years

Liuxi Zhang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. Co-author DOI 10.7150/ijbs.105289 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuling Su · 1 shared paper, 2025 · strength 0.24
- Paper FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. DOI 10.7150/ijbs.105289 ↗
Jie He · 1 shared paper, 2025 · strength 0.24
- Paper FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. DOI 10.7150/ijbs.105289 ↗
Xiaojia Li · 1 shared paper, 2025 · strength 0.24
- Paper FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. DOI 10.7150/ijbs.105289 ↗
Xinyan Huang · 1 shared paper, 2025 · strength 0.24
- Paper FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. DOI 10.7150/ijbs.105289 ↗
Keping Xie · 1 shared paper, 2025 · strength 0.24
- Paper FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance. DOI 10.7150/ijbs.105289 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.